1921
Volume 100, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The current strategy used by many funding agencies for determining how money is spent on research to help prevent infectious disease outbreaks is based on pathogen-specific priority lists. Listing disease threats provides focus for business and research planning conducive to specific goals of developing a drug, or a vaccine, or other particular product. But, this singular type of focus has consequences. This perspective explores the consequences of lists, and describes how parallel programming independent of disease lists that address what we need to do to prevent and mitigate emerging disease risks may provide benefits out of reach of a singular focus on what products we need to have.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0801
2019-05-01
2019-05-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/5/tpmd180801.html?itemId=/content/journals/10.4269/ajtmh.18-0801&mimeType=html&fmt=ahah
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0801
Loading
/content/journals/10.4269/ajtmh.18-0801
Loading

Data & Media loading...

  • Received : 04 Oct 2018
  • Accepted : 21 Nov 2018
  • Published online : 01 May 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error